Companies: 10,795·Total market cap: $144.5T
Bicara Therapeutics Inc. Common Stock

Bicara Therapeutics Inc. Common Stock

BCAXNASDAQHealthcare● Active
$20.38
+$0.28(+1.39%)
Market Cap$1.1B
P/E Ratio—
52W High$24.25
52W Low$8.48
Overview

Bicara Therapeutics Inc. Common Stock (BCAX) · Cash Flow

Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.

FMP · BCAX · as of 2026-06-10

Financial statements

Operating CF · CapEx · Free Cash Flow
Breakdown2025-122024-122023-122022-12
Operating Activities
Net Income($0.14B)($0.07B)($0.05B)($0.04B)
Depreciation & Amort.$0.00B$0.00B$0.00B$0.00B
Stock-Based Comp.$0.02B$0.01B$0.00B$0.00B
Change in Working Capital$0.01B($0.01B)($0.01B)$0.00B
Net Cash from Operations($0.11B)($0.07B)($0.05B)($0.03B)
Investing Activities
Capital Expenditure($0.00B)($0.00B)($0.00B)($0.00B)
Purchases of Investments($0.32B)$0.00B$0.00B$0.00B
Sales of Investments$0.00B$0.00B$0.00B$0.00B
Net Cash from Investing($0.32B)($0.00B)($0.00B)($0.00B)
Financing Activities
Common Stock Repurchased$0.00B$0.00B$0.00B$0.00B
Dividends Paid$0.00B$0.00B$0.00B$0.00B
Debt Issued / Repaid$0.00B$0.00B$0.00B$0.00B
Net Cash from Financing$0.03B$0.33B$0.27B$0.03B
Free Cash Flow
Free Cash Flow($0.11B)($0.07B)($0.05B)($0.03B)
FCF Margin %(computed)————

Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · B

SEC 10-K filings →SEC 10-Q filings →

Explore more Bicara Therapeutics Inc. Common Stock data

Revenue History
Quarterly & annual revenue trends
Earnings Reports
EPS beats, misses & upcoming dates
P/E Ratio
Historical price-to-earnings
Dividends
Dividend history & yield
Market Cap
Historical market cap & rank
Analyst Forecast
Consensus, price targets & estimates

About Bicara Therapeutics Inc. Common Stock (BCAX) Cash Flow Statement

Bicara Therapeutics Inc. Common Stock generated operating cash flow of ($0.11B) and free cash flow of ($0.11B) for 2025 — a FCF margin of —. Capital expenditure was ($0.00B).

Frequently asked questions

BCAX · 4 questions

Bicara Therapeutics Inc. Common Stock generated free cash flow of ($0.11B) for 2025, down 43.2% year-over-year.

BCAX free cash flowFCF margincash flow yield

· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10